We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BMKDF market cap is 13.77M. The company's latest EPS is CAD -0.0157 and P/E is -9.55.
Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 263k | 0 | 44k | 153k | 163k |
Operating Income | -703k | -554k | -719k | -1.21M | -1.81M |
Net Income | -1.22M | -1.09M | -1.45M | -1.84M | -1.43M |
Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 637k | 952k | 1.47M | 732k | 1.09M |
Total Liabilities | 1.08M | 1.03M | 2.11M | 1.88M | 1.7M |
Total Equity | -439k | -80k | -636k | -1.15M | -609k |
Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Operating | -454k | -457k | -1.2M | -915k | -983k |
Investing | -1,000 | -3k | -59k | -5k | -4k |
Financing | 1.05M | 725k | 769k | 609k | 1.07M |
Market Cap | 13.77M |
Price to Earnings Ratio | -9.55 |
Price to Sales Ratio | 83.33 |
Price to Cash Ratio | 88.24 |
Price to Book Ratio | -22.39 |
Dividend Yield | - |
Shares Outstanding | 90.89M |
Average Volume (1 week) | 300 |
Average Volume (1 Month) | 28.18k |
52 Week Change | -18.11% |
52 Week High | 0.2303 |
52 Week Low | 0.12476 |
Spread (Intraday) | 0.08 (46.31%) |
Company Name | Biomark Diagnostics Inc (PK) |
Address |
130 - 3851 shell rd richmond, british columbia V6X 2W2 |
Website | https://www.biomarkdiagnostics.com |
Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions